Inspiremd provides corporate update for shareholders

Tel aviv, israel, april 19, 2021 (globe newswire) -- inspiremd, inc. (nyse american: nspr, nspr.ws, nspr.wsb), developer of the cguard™ embolic prevention system (eps) for the prevention of stroke caused by the treatment of carotid artery disease (cad), today provided an update of recent corporate developments.
NSPR Ratings Summary
NSPR Quant Ranking